Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of Candel Therapeutics Inc (NASDAQ: CADL) was $5.59 for the day, up 2.57% from the previous closing price of $5.45. In other words, the price has increased by $2.57 from its previous closing price. On the day, 0.61 million shares were traded.
Ratios:
Our analysis of CADL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.64 and its Current Ratio is at 4.64. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on February 20, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On February 19, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $20.
On February 07, 2025, BofA Securities started tracking the stock assigning a Buy rating and target price of $15.BofA Securities initiated its Buy rating on February 07, 2025, with a $15 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 18 ’25 when Nichols William Garrett sold 45,316 shares for $8.76 per share. The transaction valued at 396,995 led to the insider holds 52,493 shares of the business.
Barone Francesca sold 32,146 shares of CADL for $281,673 on Mar 18 ’25. The Chief Scientific Officer now owns 96,527 shares after completing the transaction at $8.76 per share. On Mar 18 ’25, another insider, Tak Paul Peter, who serves as the Chief Executive Officer of the company, sold 25,772 shares for $8.77 each. As a result, the insider received 226,023 and left with 226,140 shares of the company.
Stock Price History:
Over the past 52 weeks, CADL has reached a high of $14.60, while it has fallen to a 52-week low of $3.79. The 50-Day Moving Average of the stock is 3.39%, while the 200-Day Moving Average is calculated to be -13.94%.
Shares Statistics:
A total of 49.25M shares are outstanding, with a floating share count of 36.44M. Insiders hold about 27.27% of the company’s shares, while institutions hold 38.06% stake in the company.
Earnings Estimates
The company has 1 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.12 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.53 and -$0.53 for the fiscal current year, implying an average EPS of -$0.53. EPS for the following year is -$0.62, with 1.0 analysts recommending between -$0.62 and -$0.62.
